SCHEMBL7309800

SCHEMBL7309800

CCOC(=O)c1ccc(-c2cccc(-c3cc(Nc4cccc5ncccc45)c(=O)n(CC)n3)c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 15/20 0.65
MAOB P27338 1/20 0.45
POLB P06746 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ADORA1 P30542 2/20 0.42
MAPT P10636 1/20 0.42
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
RECQL P46063 1/20 0.41
MAPK10 P53779 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7309937 0.95 PDE4B (0.58) PDE4BPOLBMEN1KMT2AADORA1
SCHEMBL7304940 0.90 PDE4B (0.59) PDE4BADORA1ADORA2AADORA2B
SCHEMBL7316395 0.89 PDE4B (0.52) PDE4BADORA1ADORA2AADORA2BRECQL
SCHEMBL7314230 0.86 PDE4B (0.52) PDE4BADORA1ADORA2AADORA2B
SCHEMBL7308904 0.85 PDE4B (0.56) PDE4BMEN1KMT2AADORA1ADORA2A
SCHEMBL7316210 0.85 PDE4B (0.58) PDE4BADORA1ADORA2AADORA2B
SCHEMBL7304693 0.85 PDE4B (0.47) PDE4BMEN1KMT2AADORA1ADORA2A
SCHEMBL7303361 0.84 PDE4B (0.49) PDE4BADORA1ADORA2AADORA2B
SCHEMBL7308807 0.83 PDE4B (0.54) PDE4BADORA1ADORA2AADORA2B
SCHEMBL7310479 0.83 PDE4B (0.54) PDE4BADORA1ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2394998-A1 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors Almirall, S.A. (ES) 2011-12-14 EP disclosed
EP-2394998-A1 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors Almirall, S.A. (ES) 2011-12-14 EP disclosed